News | Brachytherapy Systems, Women's Healthcare | April 20, 2016

Clinical Data Validates Savi Scout Breast Localization and Surgical Guidance System

Results presented at SBI/ACR Breast Imaging Symposium demonstrate high rates of clinical efficacy, intraoperative retrieval and surgical success rates

April 20, 2016 — Cianna Medical Inc. announced new clinical data evaluating the Savi Scout breast localization and surgical guidance system. Results demonstrating high rates of clinical efficacy, intra-operative retrieval and surgical success rates were presented in an electronic poster session at the Society of Breast Imaging/American College of Radiology (SBI/ACR) Breast Imaging Symposium, April 7-10.

Savi Scout, a U.S. Food and Drug Administration (FDA)-cleared tool for localizing and directing the removal of non-palpable breast lesions, became available in late 2015.

Results from the investigator-initiated trial of 154 patients demonstrated a 100 percent surgical success rate using Scout, with a low re-excision rate that is in line with rates reported for intraoperative ultrasound. In all cases where localization was performed and data are complete, targeted lesions and reflectors were successfully removed without any observed reflector migration.

“These data confirm previous findings demonstrating that real-time surgical guidance with Scout is a clinically reproducible, safe and effective technique for directing the removal of non-palpable breast lesions with no wires or radioactive materials,” said Jiyon Lee, M.D., a presenting study investigator and assistant professor in the Department of Radiology at NYU Langone Medical Center. 

Hildegard Toth, M.D., study co-investigator and associate professor in the Department of Radiology at NYU Langone, added, “In our studies, Scout demonstrated an additional benefit of decoupling the localization and surgical procedures, which may result in improved patient scheduling and work flow.”

The study also examined clinician and patient satisfaction with Scout. Radiologists favorably rated the overall patient experience at 4.1 on a scale of 1-5, where 3 was seen as Scout having equal favorability to wire localization. Using the same scale, surgeons favorably rated ease of localization at 3.9 and ability to start cases earlier at 4.9. Post-procedural survey data indicated that 97 percent of patients would recommend Scout to other patients.

The study was conducted at 11 sites, with 17 surgeons and 24 radiologists contributing. Participating centers include: University of South Florida Breast Health, Nashville Breast Center, Baylor Regional Medical at Plano, Cancer Centers of Colorado, Hackensack University Medical Center, UC Irvine Health Pacific Breast Care Center, Medical Center of Plano Complete Breast Care, Morton Plant Mease Hospital, New York University Langone Medical Center, Pink Lotus Breast Center and Texas Breast Specialists.

For more information: www.ciannamedical.com

Related Content

Densitas Enters Partnership Agreement With TeleMammography Specialists
News | Breast Density | February 14, 2019
Breast imaging analytics company Densitas Inc. announced a new collaboration partnership with TeleMammography...
Hologic Launches Unifi Analytics Business Intelligence Tool
Technology | Analytics Software | February 12, 2019
Hologic Inc. announced the U.S. launch of Unifi Analytics, a business intelligence tool that allows healthcare...
Mount Sinai's Digital 3-D Mammography Van Rolls Into New York City
News | Mammography | February 11, 2019
Mount Sinai Hospital recently launched the Mount Sinai Mobile Mammography Program (MMP), bringing essential breast...
breast density cancer awareness
News | Breast Density | February 08, 2019
Governor Michelle Lujan Grisham has signed breast density inform bill, ...
Siemens Healthineers Syngo.Breast Care Adding AI-Based Decision Support
News | Clinical Decision Support | February 05, 2019
Siemens Healthineers showcased the new planned artificial intelligence (AI)-based features with its mammography reading...
 Volpara Solutions Launches Next-Generation VolparaDensity Software to Support SmartCurve Paddles
Technology | Breast Density | January 31, 2019
Volpara Solutions Inc. received U.S. Food and Drug Administration (FDA) 510(k) clearance for new technologies used in...
QTbreasthealth Opens New Breast Ultrasound Imaging Center in Grand Rapids
News | Ultrasound Women's Health | January 30, 2019
January 30, 2019 — QTbreasthealth launched a center in Grand Rapids, Mich., featuring its quantitative transmission
Traditional mammography continues to be the gold standard for breast cancer screening technologies. However, use of 3-D breast tomosynthesis is growing rapidly.

Traditional mammography continues to be the gold standard for breast cancer screening technologies. However, use of 3-D breast tomosynthesis is growing rapidly.

Feature | Breast Imaging | January 30, 2019 | By Jeff Zagoudis
The importance of early detection of...
Wefight Unveils Vik Breast Chatbot at CES 2019
News | Artificial Intelligence | January 25, 2019
French startup company Wefight unveiled the English version of its Vik Breast chatbot for breast cancer patients at the...
New Pathology Guideline Advances Accuracy in Breast Cancer Testing
News | Digital Pathology | January 25, 2019
January 25, 2019 — The College of American Pathologists (CAP) published the first-ever evidence-based clinical practi